4//SEC Filing
MAGNUSON TERRY 4
Accession 0001181158-11-000003
CIK 0001003124other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 3:36 PM ET
Size
20.0 KB
Accession
0001181158-11-000003
Insider Transaction Report
Form 4
MAGNUSON TERRY
Director
Transactions
- Award
Common Stock
2011-05-18+1,139→ 17,633 total - Award
Stock Options (to buy)
2011-05-18+9,095→ 9,095 totalExercise: $28.52From: 2011-05-18Exp: 2021-05-18→ Common Stock (9,095 underlying)
Holdings
- 6,485
Stock Options (to buy)
Exercise: $41.32From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,485 underlying) - 10,496
Stock Options (to buy)
Exercise: $24.52From: 2010-05-20Exp: 2020-05-20→ Common Stock (10,496 underlying) - 14,053
Stock Options (to buy)
Exercise: $19.19From: 2009-05-20Exp: 2019-05-20→ Common Stock (14,053 underlying) - 9,090
Stock Options (to buy)
Exercise: $24.26From: 2011-07-30Exp: 2020-07-30→ 9090 (9,090 underlying) - 6,341
Stock Options (to buy)
Exercise: $32.67From: 2007-05-16Exp: 2017-05-15→ Common Stock (6,341 underlying) - 5,650
Stock Options (to buy)
Exercise: $22.98From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,650 underlying) - 12,421
Stock Options (to buy)
Exercise: $12.37From: 2002-05-15Exp: 2012-05-14→ Common Stock (12,421 underlying) - 16,561
Stock Options (to buy)
Exercise: $13.12From: 2003-05-14Exp: 2013-05-13→ Common Stock (16,561 underlying) - 4,113
Stock Options (to buy)
Exercise: $34.18From: 2006-05-17Exp: 2016-05-16→ Common Stock (4,113 underlying)
Footnotes (2)
- [F1]Direct Holdings include an anti-dilution adjustment of 295 shares to restricted stock held made in connection with the June 14, 2010 spin-off of Furiex Pharmaceuticals, Inc.
- [F2]The options vest in three equal increments on 7/30/2011, 7/30/2012 and 7/30/2013.
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeother
Related Parties
1- filerCIK 0001181158
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 3:36 PM ET
- Size
- 20.0 KB